Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-2805-2026

Permobil Inc recalls M5 Corpus Power Wheelchair REF

Permobil IncLebanon, TN, United StatesReported Aug 5, 2026 · 6 days ago
Legal News Analyst ·

Reason for recall

This recall is being reported retroactively. Power Platform firmware is missing specific drive inhibit logic. This issue may allow the chair to drive under restricted conditions, and may create an unstable condition in certain circumstances.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Affected products & lots

  • M5 Corpus Power Wheelchair REF120032
    UDI-DI 17330818334562

What the firm is doing

On June 10, 2025 Permobil issued a technical bulletin (recall notice) via Email to affected consignees. Permobil informed consignees of the following: 1. Cellular connection is required to receive and install the firmware update. 2. It is important to not use the wheelchair when the firmware update is in process (as indicated on the display of the input device). 3. Specific Remote Update Instructions are available if needed in addition to the on-screen information. 4. A confirmation of the completed update will be shown on the joystick display when the update successfully completes. 5. If you have any questions or concerns, please contact the Permobil Customer Experience team at (800) 736-0925. 1.

DistributionShow details

Worldwide - US: Nationwide distribution in the states of AL, AR, AZ, CA, CO, CT, FL, GA, HI, IA, ID, IL, IN, KY, ME, MI, MN, MO, MS, MT, NC, ND, NJ, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, VT, WA, WI, WV, WY and the country of CANADA.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls